Skip to main content
. 2025 Oct 30;2025:7800569. doi: 10.1155/grp/7800569

Table 4.

Identification of druggable targets.

Gene Target name Drug name Indication/associated conditions
P2RY14 P2Y Purinoceptor 14 Investigational MRS2690 Discovery agent
In clinical trials MC-1 Coronary artery disease
Approved, investigational Promethazine Allergic conditions, nausea and vomiting, and motion sickness

ATRAID Apoptosis-related Protein 3 Druggable NA NA